Benjamin L Trzaskoma

Suggest Changes
Learn More
OBJECTIVES To better understand the effects of drotrecogin alfa (activated) (DrotAA) in severe sepsis patients, and the natural progression of severe sepsis, by creating a database of severe sepsis(More)
OBJECTIVE To demonstrate that drotrecogin alfa (activated) has an acceptable safety profile 1 yr from randomization. DESIGN One-year follow-up of patients participating in a placebo-controlled(More)
  • 1